LHC Group - common stock (LHCG): Price and Financial Metrics


LHC Group - common stock (LHCG): $214.75

2.38 (+1.12%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LHCG POWR Grades


  • LHCG scores best on the Quality dimension, with a Quality rank ahead of 93.21% of US stocks.
  • The strongest trend for LHCG is in Value, which has been heading up over the past 31 weeks.
  • LHCG's current lowest rank is in the Momentum metric (where it is better than 46.52% of US stocks).

LHCG Stock Summary

  • LHCG's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 225.35 -- higher than 86.04% of US-listed equities with positive expected earnings growth.
  • With a year-over-year growth in debt of -73.78%, LHC Group Inc's debt growth rate surpasses merely 3.94% of about US stocks.
  • In terms of volatility of its share price, LHCG is more volatile than merely 3.2% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to LHC Group Inc are BMI, KFY, SAIA, SEIC, and AMED.
  • LHCG's SEC filings can be seen here. And to visit LHC Group Inc's official web site, go to www.lhcgroup.com.

LHCG Valuation Summary

  • In comparison to the median Healthcare stock, LHCG's price/earnings ratio is 60.59% higher, now standing at 54.6.
  • LHCG's price/sales ratio has moved up 1.1 over the prior 196 months.
  • Over the past 196 months, LHCG's price/earnings ratio has gone up 29.2.

Below are key valuation metrics over time for LHCG.

Stock Date P/S P/B P/E EV/EBIT
LHCG 2019-05-31 1.8 2.7 46.1 33.9
LHCG 2019-03-28 1.9 2.6 53.2 37.4
LHCG 2017-05-15 1.2 2.7 28.8 18.5
LHCG 2013-03-26 0.6 1.4 14.1 8.5
LHCG 2012-11-14 0.5 1.1 10.5 6.8
LHCG 2011-04-15 0.9 2.0 11.2 6.8

LHCG Growth Metrics

  • Its 2 year net cashflow from operations growth rate is now at 136.5%.
  • Its 3 year price growth rate is now at 181.66%.
  • Its 5 year net income to common stockholders growth rate is now at 228.18%.
Over the past 49 months, LHCG's revenue has gone up $1,136,279,000.

The table below shows LHCG's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 2,075.168 598.517 124.231
2020-12-31 2,063.204 529.247 111.596
2020-09-30 2,062.19 481.415 103.019
2020-06-30 2,060.005 508.007 118.586
2020-03-31 2,090.527 74.57 98.894
2019-12-31 2,080.241 130.462 95.726

LHCG Price Target

For more insight on analysts targets of LHCG, see our LHCG price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $251.80 Average Broker Recommendation 1.27 (Strong Buy)

LHCG Stock Price Chart Interactive Chart >

Price chart for LHCG

LHCG Price/Volume Stats

Current price $214.75 52-week high $236.81
Prev. close $212.37 52-week low $170.01
Day low $209.03 Volume 165,700
Day high $215.27 Avg. volume 168,619
50-day MA $203.78 Dividend yield N/A
200-day MA $204.15 Market Cap 6.80B

LHC Group - common stock (LHCG) Company Bio


LHC Group is a national provider of post-acute healthcare services, providing quality, cost-effective healthcare to patients within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice and community-based services and provides inpatient care through long-term acute care hospitals. The company was founded in 1994 and is based in Lafayette, Louisiana.

LHCG Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$214.75$816.56 318%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for LHC Group Inc. To summarize, we found that LHC Group Inc ranked in the 80th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 320.33%. The most interesting components of our discounted cash flow analysis for LHC Group Inc ended up being:

  • The company's debt burden, as measured by earnings divided by interest payments, is 103.44; that's higher than 92.73% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet reveals debt to be 2% of the company's capital (with equity being the remaining amount). Approximately just 9.47% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • LHCG's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 54.51% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%310%
1%314%
2%318%
3%322%
4%327%
5%331%

INVA, KMDA, SSY, HBIO, and FTLF can be thought of as valuation peers to LHCG, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


LHCG Latest News Stream


Event/Time News Detail
Loading, please wait...

LHCG Latest Social Stream


Loading social stream, please wait...

View Full LHCG Social Stream

Latest LHCG News From Around the Web

Below are the latest news stories about LHC Group Inc that investors may wish to consider to help them evaluate LHCG as an investment opportunity.

LHC Group (LHCG) Reports Next Week: Wall Street Expects Earnings Growth

LHC (LHCG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 28, 2021

Were Hedge Funds Right About LHC Group, Inc. (LHCG)?

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]

Yahoo | July 26, 2021

Home Healthcare Market 2021 Trending News, Industry Analysis, Size, Share, Growth, Trends and Forecast to 2028 LHC Group, Inc., BAYADA Home Health Care, Invacare Corporation, Abbott Care, Amedisys

The home healthcare market was valued at US$ 315,139.27 million in 2020 and is projected to reach US$ 621,565.89 million by 2028; it is expected to grow at a CAGR of 8.9% from 2020 to 2028. Home healthcare comprises a wide

OpenPR | July 23, 2021

3 Reasons to Add LHC Group (LHCG) Stock to Your Portfolio

Investors continue to be optimistic about LHC Group (LHCG) owing to its slew of deals and a broad array of services.

Yahoo | July 14, 2021

LHC Group (LHCG) & SCP Health to Offer Home Health Services

LHC Group (LHCG) collaborates with SCP Health to provide innovative and advanced in-home healthcare services.

Yahoo | July 12, 2021

Read More 'LHCG' Stories Here

LHCG Price Returns

1-mo N/A
3-mo 6.51%
6-mo 5.17%
1-year 7.48%
3-year 131.31%
5-year 430.12%
YTD 0.67%
2020 54.85%
2019 46.74%
2018 53.27%
2017 34.03%
2016 0.91%

Continue Researching LHCG

Here are a few links from around the web to help you further your research on LHC Group Inc's stock as an investment opportunity:

LHC Group Inc (LHCG) Stock Price | Nasdaq
LHC Group Inc (LHCG) Stock Quote, History and News - Yahoo Finance
LHC Group Inc (LHCG) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8601 seconds.